Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

Mariasanta Napolitano; Sergio Siragusa

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Other

Abstract

No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).

Lingua originale	English
Numero di pagine	2
Stato di pubblicazione	Published - 2012

Accesso al documento

OA Link

Fingerprint Entra nei temi di ricerca di 'Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER'. Insieme formano una fingerprint unica.

Cita questo

Napolitano, M., & Siragusa, S. (2012). Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

@conference{6dc5bfe7ca9a43bf8f054eab974fd0cb,

title = "Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER",

abstract = "No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).",

keywords = "Adverse Events, Inherited Fasctor VII deficiency",

author = "Mariasanta Napolitano and Sergio Siragusa",

year = "2012",

language = "English",

}

TY - CONF

T1 - Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

AU - Napolitano, Mariasanta

AU - Siragusa, Sergio

PY - 2012

Y1 - 2012

N2 - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).

AB - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).

KW - Adverse Events

KW - Inherited Fasctor VII deficiency

UR - http://hdl.handle.net/10447/76370

M3 - Other

ER -